Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 50 of 337
DOES HIV IMPACT COVID-19 SUSCEPTIBILITY OR SEVERITY?   (ABSTRACT 31)
Julia Del Amo
Ministry of Health, Madrid, Spain
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
THE IMPACT OF COVID-19 ON THE HIV PANDEMIC WORLDWIDE   (ABSTRACT 32)
Andrew D Kambugu
Makerere University, Kampala, Uganda
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
THE IMPACT OF COVID-19 BEYOND HIV   (ABSTRACT 33)
Helen Bygrave
International AIDS Society, London, United Kingdom
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
FEAR AND COVID-19: EXPERIENCES ON THE GROUND   (ABSTRACT 34)
Francois Venter
Ezintsha, Johannesburg, South Africa
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
FROM GENOME TO FUNCTION: PHENOTYPIC CHARACTERISATION OF PANDEMIC SARS-COV-2 VARIANTS   (ABSTRACT 23)
Volker Thiel
University of Bern, Bern, Switzerland
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
IMMUNE EVASION STRATEGIES BY SARS-COV-2: NSP1 AND BEYOND   (ABSTRACT 24)
Konstantin Sparrer
Ulm University, Ulm, Germany
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
SHARED VULNERABILITIES AND DIFFERENT COUNTERMEASURES OF HIV AND SARS-COV-2   (ABSTRACT 25)
Eric O Freed
National Cancer Institute, Frederick, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
IMMUNE RESPONSES TO SARS-COV-2   (ABSTRACT 26)
Akiko Iwasaki
Yale University, New Haven, CT, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
SYMPOSIUM CONVENER
Wesley I Sundquist
University of Utah School of Medicine, Salt Lake City, UT, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
LIVE-CELL IMAGING: CAPSID TRAFFICKING TO THE NUCLEUS   (ABSTRACT 19)
Barbara Müller
University Hospital Heidelberg, Heidelberg, Germany
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
LIVE-CELL IMAGING OF HIV-1 NUCLEAR IMPORT, UNCOATING, AND PROVIRUSES   (ABSTRACT 20)
Vinay K Pathak
National Cancer Institute, Frederick, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
VISUALIZATION OF HIV-1 CAPSID-DEPENDENT REPLICATION IN VITRO   (ABSTRACT 21)
Barbie Ganser-Pornillos
University of Virginia, Charlottesville, VA, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
LENACAPAVIR (GS-6207): FIRST CLINICALLY ACTIVE LONG-ACTING INHIBITOR OF HIV CAPSID   (ABSTRACT 22)
Tomas Cihlar
Gilead Sciences, Inc, Foster City, CA, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
THE POTENTIAL OF LONG-ACTING INJECTABLE DRUGS FOR PREVENTION AND TREATMENT OF TUBERCULOSIS   (ABSTRACT 27)
Eric Nuermberger
Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
PREGNANCY, HIV, AND TUBERCULOSIS: CURRENT PRACTICES AND RESEARCH OPPORTUNITIES   (ABSTRACT 28)
Jyoti S Mathad
Weill Cornell Medical College, New York, NY, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
ADVANCES IN PEDIATRIC TUBERCULOSIS PREVENTION AND TREATMENT   (ABSTRACT 29)
Nicole Salazar-Austin
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
IMPACT OF COVID-19 PANDEMIC ON HIV AND TUBERCULOSIS: WHO PERSPECTIVE   (ABSTRACT 30)
Souyma Swaminathan
World Health Organization, Geneva, Switzerland
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
SINGLE VASCULAR CELL HETEROGENEITY IN HEALTH AND DISEASE: A COVID-19 UPDATE   (ABSTRACT 49)
Peter Carmeliet
VIB KU Leuven Center for Cancer Biology, Leuven, Belgium
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
BODY ON FIRE: MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN   (ABSTRACT 50)
Elizabeth A Whittaker
Imperial College Healthcare NHS Trust, London, United Kingdom
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
THINK ABOUT IT: NEUROLOGIC MANIFESTATIONS OF COVID-19   (ABSTRACT 51)
Benedict D Michael
University of Liverpool, Liverpool, United Kingdom
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
COVID-19: CONCERNS OF THE HEART   (ABSTRACT 52)
Valentina O Puntmann
Goethe University, University Hospital Frankfurt, Frankfurt, Germany
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
HOW TO GENERATE GOOD KILLERS BY INITIATING ART (NOT TOO) EARLY?   (ABSTRACT 42)
Lydie Trautmann
Vaccine and Gene Therapy Institute, Beaverton, OR, USA
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
BREAKING THE B-CELL FOLLICLE BARRIER TO ELIMINATE VIRAL RESERVOIRS   (ABSTRACT 43)
Afam Okoye
Oregon Health & Science University, Beaverton, OR, USA
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
INTRINSIC RESISTANCE OF RESERVOIR CELLS TO IMMUNE KILLING   (ABSTRACT 41)
R. Brad Jones
Weill Cornell Medicine, New York, NY, USA
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
TYPE I INTERFERON RESISTANCE OF REBOUND HIV-1   (ABSTRACT 44)
Beatrice H Hahn
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
TRIPLE DRUG ART, DUAL ART, OR JUST ART?   (ABSTRACT 45)
Jose R Arribas
Hospital Universitario La Paz, Madrid, Spain
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
NOVEL ANTIRETROVIRAL THERAPIES IN CLINICAL DEVELOPMENT   (ABSTRACT 46)
Alexandra L Calmy
Geneva University Hospitals, Geneva, Switzerland
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
ARVS AND ART FOR NEWBORNS AND INFANTS: A LAST FRONTIER   (ABSTRACT 47)
Moherndran Archary
University of KwaZulu-Natal, Durban, South Africa
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
GOT ANYTHING FOR THIS COUGH? NEW ANTIVIRALS FOR TREATMENT OF SARS-COV-2   (ABSTRACT 48)
Davey M Smith
University of California San Diego, San Diego, CA, USA
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
YOUNG WOMEN: ADHERENCE, EFFECT, AND RETENTION   (ABSTRACT 53)
Thesla Palanee-Phillips
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
CHALLENGES AND OPPORTUNITIES IN IMPLEMENTING PREP IN KEY POPULATIONS   (ABSTRACT 54)
Greg A Millett
amfAR, District of Columbia, DC, USA
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
MODELS OF DELIVERING PREP IN EAST AFRICA: INNOVATIONS AND LESSONS LEARNED   (ABSTRACT 55)
Moses R Kamya
Department of Medicine, Makerere University, Kampala, Uganda
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
INCORPORATING INJECTABLE PREP AND NEWER FORMULATIONS INTO LMIC   (ABSTRACT 56)
Yogan Pillay
Clinton Health Access Initiative, Pretoria, South Africa
from CROI 2021 on March 9, 2021 12:00 AM-12:00 AM
PREP DURING PREGNANCY AND BREASTFEEDING   (ABSTRACT 66)
John Kinuthia
University of Nairobi, Nairobi, Kenya
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
IMPROVING ADOLESCENT PREP USE: UNDERSTANDING DEVELOPMENTAL PROCESSES AND CONTEXT   (ABSTRACT 68)
Claude A Mellins
New York State Psychiatric Institute and Columbia University, New York, NY, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
PREP ADHERENCE INTERVENTIONS FOR ADOLESCENTS AND YOUNG ADULTS   (ABSTRACT 67)
Sybil Hosek
Stroger Hospital of Cook County, Chicago, IL, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
IMPROVING HOW WE MARKET PREP TO YOUTH   (ABSTRACT 69)
Elzette Rousseau
University of Cape Town, Cape Town, South Africa
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
LESSONS LEARNED AND CHALLENGES IN COVID-19 VACCINE TRIALS   (ABSTRACT 74)
Kathleen Neuzil
University of Maryland School of Medicine, Baltimore, MD, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
EQUITABLE ROLL-OUT OF COVID-19 VACCINES IN THE UNITED STATES   (ABSTRACT 75)
Michelle Williams
Harvard T.H. Chan School of Public Health, Boston, MA, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
VACCINE ACCEPTANCE   (ABSTRACT 76)
Saad Omer
Yale University, New Haven, CT, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
GLOBAL DISTRIBUTION OF THE SARS-COV-2 VACCINE   (ABSTRACT 77)
Nicole Lurie
Coalition for Epidemic Preparedness Innovations, Washington, DC, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
HEPATITIS C ELIMINATION: WHAT'S TAKING SO LONG?   (ABSTRACT 70)
Annie Luetkemeyer
University of California San Francisco, San Francisco, CA, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
MECHANISMS AND TREATMENTS OF STEATOSIS IN HIV   (ABSTRACT 71)
Steven Grinspoon
Harvard Medical School, Boston, MA, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
HARNESSING IMMUNITY TO CURE HBV   (ABSTRACT 72)
Ulrike Protzer
Technical University of Munich, Munich, Germany
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
NEW PROSPECTS FOR THE TREATMENT OF HBV   (ABSTRACT 73)
Heiner Wedemeyer
Hannover Medical School, Hannover, Germany
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
SYMPOSIUM CONVENER
Dennis L Kolson
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
NOVEL FINDINGS OF NEURONAL MODULATION OF HIV EXPRESSION IN MICROGLIA   (ABSTRACT 62)
Jonathan Karn
Case Western Reserve University, Cleveland, OH, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
ROLE OF CNS CD4 T CELLS AND MACROPHAGES IN SIV NEUROPATHOGENESIS AND RESERVOIRS   (ABSTRACT 63)
Vanessa M Hirsch
National Institutes of Health, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
MYELOID CNS HIV RESERVOIRS...THE DEBATE CONTINUES   (ABSTRACT 64)
Lishomwa Ndhlovu
Weill Cornell Medicine, New York, NY, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
LESSONS FROM CNS HIV ESCAPE AND ATI FOR UNDERSTANDING HIV PERSISTENCE IN THE CNS   (ABSTRACT 65)
Sarah B Joseph
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2021 on March 10, 2021 12:00 AM-12:00 AM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 50 of 337